Prostate Cancer Clinical Trials in San Antonio

Showing 201-220 of 236 trials

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

NCT00203424

The purpose of this study is to evaluate the safety and effectiveness of bevacizumab plus erlotinib following radical prostatectomy.

Prostate Cancer

Translational Oncology Research International23 participantsStarted Jan 2006

Alhambra, California, United States • Bakersfield, California, United States • Fullerton, California, United States +13 more locations

COMPLETEDNA< 1 mile

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

NCT00937833

The purpose of this study is to determine the impact of an absorbable urethrovesical sling on the post-operative return of urinary continence after robot-assisted radical prostatectomy.

Urinary IncontinenceProstate Cancer

Cook Group Incorporated150 participantsStarted Nov 2009

Indianapolis, Indiana, United States • San Antonio, Texas, United States

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

Prostate Cancer Trials in Other Cities

A Trial of Degarelix in Patients With Prostate Cancer

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

3-AP in Treating Patients With Advanced Prostate Cancer

Multi-site Decision Impact Study for Decipher

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Other Conditions in San Antonio